Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 30:54:101274.
doi: 10.1016/j.lanwpc.2024.101274. eCollection 2025 Jan.

Spirometric pattern and cardiovascular risk: a prospective study of 0.3 million Chinese never-smokers

Collaborators, Affiliations

Spirometric pattern and cardiovascular risk: a prospective study of 0.3 million Chinese never-smokers

Yinqi Ding et al. Lancet Reg Health West Pac. .

Abstract

Background: Existing studies have not provided robust evidence about the CVD risk of non-smoking patients with restrictive spirometric pattern (RSP) or airflow obstruction (AFO), and how the risk is modified by body shape. We aimed to bridge the gap.

Methods: We used never-smokers' data from the China Kadoorie Biobank (CKB) and performed Cox models by sex (278,953 females and 50,845 males). Spirometry was used to assess the baseline spirometric pattern. CVD outcomes were captured through multiple sources.

Findings: Females' results were presented primarily, though males' results were similar. During a median 12-year (maximum 14.5 years) follow-up, both RSP and AFO patients had increased risks of acute myocardial infarction (AMI), other ischaemic heart disease (other IHD), heart failure, pulmonary heart disease, arrhythmia, and intracerebral haemorrhage (ICH). RSP was also associated with ischaemic stroke (IS). The HRs (95% CIs) for AFO in females ranged from 1.29 (1.15-1.45) for ICH to 8.84 (7.79-10.03) for pulmonary heart disease, while those for RSP ranged from 1.11 (1.08-1.15) for IS to 3.17 (2.80-3.59) for pulmonary heart disease. These risks increased with the severity of AFO and reduced FVC. RSP/AFO was more strongly associated with other IHD, heart failure, and pulmonary heart disease in underweight females than in normal and obese counterparts, respectively.

Interpretation: With the confounding of smoking fully controlled, both RSP and AFO were associated with higher risks of various CVD outcomes, which further increased with the severity of AFO and reduced FVC. These associations were even stronger in underweight individuals.

Funding: National Natural Science Foundation of China, National Key Research and Development Program of China, Ministry of Science and Technology of the People's Republic of China, Kadoorie Charitable Foundation, UK Wellcome Trust, UK Medical Research Council, Cancer Research UK, and British Heart Foundation.

Keywords: Cardiovascular disease; Chronic obstructive pulmonary disease; Forced expiratory volume in one second; Obesity; Restrictive lung function; Underweight.

PubMed Disclaimer

Conflict of interest statement

We declare that we have no conflicts of interest.

Figures

Fig. 1
Fig. 1
Associations between spirometric pattern and CVD outcomes among females. AFO = airflow obstruction; CI = confidence interval; CVD = cardiovascular disease; FEV1 = forced expiratory volume in 1 s; FEV1%P = FEV1 percent predicted; FVC = forced vital capacity; FVC%P = FVC percent predicted; HR = hazard ratio; RSP = restrictive spirometric pattern. “Normal” refers to FEV1/FVC ≥ 0.7 and FVC ≥ 80% predicted; “With RSP” refers to FEV1/FVC ≥ 0.7 and FVC < 80% predicted; “With AFO” refers to FEV1/FVC < 0.7. Analyses of FVC%P and FEV1%P were conducted among participants with RSP or AFO, respectively. The HRs (95% CIs) in red were statistically significant after Bonferroni correction (<0.0062). Multivariable models were adjusted for age, level of education, occupation, marital status, household income, alcohol consumption, physical activity, intake frequencies of red meat, fruits, and vegetables, body mass index, waist circumference, fuel types currently used in cooking, fuel types currently used in heating, years of cooking with solid fuels, years of heating with solid fuels, stove ventilation in the baseline house, passive smoking, and family histories of heart disease and stroke.
Fig. 2
Fig. 2
Associations between severity of reduced FVC and CVD outcomes among females without AFO. AFO = airflow obstruction; CI = confidence interval; CVD = cardiovascular disease; FEV1 = forced expiratory volume in 1 s; FVC = forced vital capacity; HR = hazard ratio. “Normal” refers to FEV1/FVC ≥ 0.7 and FVC z-score > −1.65; “Mild” refers to FEV1/FVC ≥ 0.7 and −2.5 ≤ FVC z-score ≤ −1.65; “Moderate” refers to FEV1/FVC ≥ 0.7 and −4 ≤ FVC z-score < −2.5; “Severe” refers to FEV1/FVC ≥ 0.7 and FVC z-score < −4. The HRs (95% CIs) in red were statistically significant after Bonferroni correction (<0.0062). Multivariable models were adjusted for age, level of education, occupation, marital status, household income, alcohol consumption, physical activity, intake frequencies of red meat, fruits, and vegetables, body mass index, waist circumference, fuel types currently used in cooking, fuel types currently used in heating, years of cooking with solid fuels, years of heating with solid fuels, stove ventilation in the baseline house, passive smoking, and family histories of heart disease and stroke.
Fig. 3
Fig. 3
Associations between GOLD grades of AFO and CVD outcomes among females without RSP. AFO = airflow obstruction; CI = confidence interval; CVD = cardiovascular disease; FEV1 = forced expiratory volume in 1 s; FEV1%P = FEV1 percent predicted; FVC = forced vital capacity; GOLD = Global Initiative for Chronic Obstructive Lung Disease; HR = hazard ratio; RSP = restrictive spirometric pattern. “GOLD 1” refers to FEV1/FVC < 0.7 and FEV1%P ≥ 80%; “GOLD 2” refers to FEV1/FVC < 0.7 and 50% ≤ FEV1%P < 80%; “GOLD 3” refers to FEV1/FVC < 0.7 and 30% ≤ FEV1%P < 50%; “GOLD 4” refers to FEV1/FVC < 0.7 and FEV1%P < 30%. The HRs (95% CIs) in red were statistically significant after Bonferroni correction (<0.0062). Multivariable models took those with FEV1/FVC ≥ 0.7 and FVC ≥ 80% predicted (the “normal” group) as the reference, and were adjusted for age, level of education, occupation, marital status, household income, alcohol consumption, physical activity, intake frequencies of red meat, fruits, and vegetables, body mass index, waist circumference, fuel types currently used in cooking, fuel types currently used in heating, years of cooking with solid fuels, years of heating with solid fuels, stove ventilation in the baseline house, passive smoking, and family histories of heart disease and stroke.
Fig. 4
Fig. 4
Associations between spirometric pattern and CVD outcomes stratified by body shape among females. AFO = airflow obstruction; BMI = body mass index; CI = confidence interval; CVD = cardiovascular disease; FEV1 = forced expiratory volume in 1 s; FVC = forced vital capacity; HR = hazard ratio; RSP = restrictive spirometric pattern; WC = waist circumference. In the spirometric pattern, “With RSP” refers to FEV1/FVC ≥ 0.7 and FVC < 80% predicted; “With AFO” refers to FEV1/FVC < 0.7. In the body shape, “Underweight” refers to BMI < 18.5 kg/m2; “Normal” refers to BMI 18.5–23.9 kg/m2 and WC < 80/85 cm; “General or central obesity” refers to BMI ≥ 24 kg/m2, or BMI 18.5–23.9 kg/m2 and WC ≥ 80/85 cm. Multivariable models took those with FEV1/FVC ≥ 0.7 and FVC ≥ 80% predicted (the “normal” group) as the reference, and were adjusted for age, level of education, occupation, marital status, household income, alcohol consumption, physical activity, intake frequencies of red meat, fruits, and vegetables, fuel types currently used in cooking, fuel types currently used in heating, years of cooking with solid fuels, years of heating with solid fuels, stove ventilation in the baseline house, passive smoking, and family histories of heart disease and stroke.

References

    1. Ramalho S.H.R., Shah A.M. Lung function and cardiovascular disease: a link. Trends Cardiovasc Med. 2021;31(2):93–98. - PMC - PubMed
    1. Roth G.A., Mensah G.A., Johnson C.O., et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. - PMC - PubMed
    1. Adeloye D., Song P., Zhu Y., Campbell H., Sheikh A., Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–458. - PMC - PubMed
    1. Morgan A.D., Zakeri R., Quint J.K. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018;12 - PMC - PubMed
    1. Yang I.A., Jenkins C.R., Salvi S.S. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med. 2022;10(5):497–511. - PubMed

LinkOut - more resources